Ophthalmic Polifarma area is the last entry in the group. Thanks to the agreement signed with a historical company in this market and a mature and consolidated portfolio, Polifarma is committed to the new project with the experience of almost a century of pharmaceutical, for a better quality of life.
Over the years, Polifarma has established itself in a significant way on the cardiovascular market, associated with the medical class, above all, in this therapeutic area. In particular, Polifarma has concentrated on the treatment of hypertension, one of the main risk factors of cardiovascular disease.
Registrati al sito approfitta
dei contenuti e dei servizi a te dedicati!